CA2454027A1 - Residual solvent extraction method and microparticles produced thereby - Google Patents
Residual solvent extraction method and microparticles produced thereby Download PDFInfo
- Publication number
- CA2454027A1 CA2454027A1 CA002454027A CA2454027A CA2454027A1 CA 2454027 A1 CA2454027 A1 CA 2454027A1 CA 002454027 A CA002454027 A CA 002454027A CA 2454027 A CA2454027 A CA 2454027A CA 2454027 A1 CA2454027 A1 CA 2454027A1
- Authority
- CA
- Canada
- Prior art keywords
- microparticles
- residual solvent
- solvent
- extraction method
- solvent extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/20—After-treatment of capsule walls, e.g. hardening
- B01J13/206—Hardening; drying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J14/00—Chemical processes in general for reacting liquids with liquids; Apparatus specially adapted therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
- B01J19/121—Coherent waves, e.g. laser beams
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
- B01J19/122—Incoherent waves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/24—Stationary reactors without moving elements inside
- B01J19/2415—Tubular reactors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J8/00—Chemical or physical processes in general, conducted in the presence of fluids and solid particles; Apparatus for such processes
- B01J8/02—Chemical or physical processes in general, conducted in the presence of fluids and solid particles; Apparatus for such processes with stationary particles, e.g. in fixed beds
- B01J8/0242—Chemical or physical processes in general, conducted in the presence of fluids and solid particles; Apparatus for such processes with stationary particles, e.g. in fixed beds the fluid flow within the bed being predominantly vertical
- B01J8/025—Chemical or physical processes in general, conducted in the presence of fluids and solid particles; Apparatus for such processes with stationary particles, e.g. in fixed beds the fluid flow within the bed being predominantly vertical in a cylindrical shaped bed
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J2219/0873—Materials to be treated
- B01J2219/0877—Liquid
Abstract
Methods for preparing microparticles having reduced residual solvent levels, Microparticles are contacted with a non-aqueous washing system to reduce the level of residual solvent in the microparticles, Preferred non-aqueous washing systems include 100% ethanol and a blend of ethanol and heptane. A solvent blend of a hardening solvent and a washing solvent can be used to harden and wash microparticles in a single step, thereby eliminating the need for a post-hardening wash step.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/942,631 | 2001-08-31 | ||
US09/942,631 US6824822B2 (en) | 2001-08-31 | 2001-08-31 | Residual solvent extraction method and microparticles produced thereby |
PCT/US2002/026953 WO2003020245A1 (en) | 2001-08-31 | 2002-08-26 | Residual solvent extraction method and microparticles produced thereby |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2454027A1 true CA2454027A1 (en) | 2003-03-13 |
CA2454027C CA2454027C (en) | 2008-04-15 |
Family
ID=25478380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002454027A Expired - Lifetime CA2454027C (en) | 2001-08-31 | 2002-08-26 | Residual solvent extraction method and microparticles produced thereby |
Country Status (15)
Country | Link |
---|---|
US (8) | US6824822B2 (en) |
EP (2) | EP1420762B1 (en) |
JP (4) | JP2005502674A (en) |
AT (1) | ATE501711T1 (en) |
CA (1) | CA2454027C (en) |
CY (1) | CY1112348T1 (en) |
DE (1) | DE60239469D1 (en) |
DK (1) | DK1420762T3 (en) |
ES (1) | ES2362865T3 (en) |
HK (1) | HK1066465A1 (en) |
IL (2) | IL160378A0 (en) |
MX (1) | MXPA04001765A (en) |
NZ (1) | NZ531165A (en) |
PT (1) | PT1420762E (en) |
WO (1) | WO2003020245A1 (en) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6824822B2 (en) * | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
US7666445B2 (en) | 2000-10-20 | 2010-02-23 | The Trustees Of The University Of Pennsylvania | Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
US8221778B2 (en) | 2005-01-12 | 2012-07-17 | The Trustees Of The University Of Pennsylvania | Drug-containing implants and methods of use thereof |
WO2007011955A2 (en) * | 2005-07-18 | 2007-01-25 | The Trustees Of The University Of Pennsylvania | Drug-containing implants and methods of use thereof |
CA2553254C (en) * | 2004-01-12 | 2013-12-17 | The Trustees Of The University Of Pennsylvania | Long-term delivery formulations and methods of use thereof |
US8329203B2 (en) | 2004-01-12 | 2012-12-11 | The Trustees Of The University Of Pennsylvania | Drug-containing implants and methods of use thereof |
US7456254B2 (en) * | 2004-04-15 | 2008-11-25 | Alkermes, Inc. | Polymer-based sustained release device |
MXPA06011924A (en) * | 2004-04-15 | 2007-06-11 | Alkermes Inc | Polymer-based sustained release device. |
US20060110423A1 (en) * | 2004-04-15 | 2006-05-25 | Wright Steven G | Polymer-based sustained release device |
FR2869801B1 (en) * | 2004-05-05 | 2008-09-12 | Ethypharm Sa | PROCESS FOR THE PREPARATION OF PROLONGED RELEASE COMPOSITIONS AND USE THEREOF FOR THE TREATMENT OF CHRONIC AFFECTIONS OF THE CENTRAL NERVOUS SYSTEM (CNS) |
ES2618028T3 (en) | 2004-07-19 | 2017-06-20 | Biocon Limited | Insulin-oligomer conjugates, formulations and uses thereof. |
WO2006078841A1 (en) * | 2005-01-21 | 2006-07-27 | President And Fellows Of Harvard College | Systems and methods for forming fluidic droplets encapsulated in particles such as colloidal particles |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
JP5693817B2 (en) | 2005-08-19 | 2015-04-01 | アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc | Diabetes treatment and weight loss |
CN101453982B (en) | 2006-05-30 | 2011-05-04 | 精达制药公司 | Two-piece, internal-channel osmotic delivery system flow modulator |
US20080075777A1 (en) * | 2006-07-31 | 2008-03-27 | Kennedy Michael T | Apparatus and methods for preparing solid particles |
ES2422864T3 (en) | 2006-08-09 | 2013-09-16 | Intarcia Therapeutics, Inc | Osmotic release systems and piston units |
CA2671670C (en) * | 2006-12-18 | 2015-02-10 | Takeda Pharmaceutical Company Limited | Sustained-release composition and method for producing the same |
JP2010522196A (en) * | 2007-03-22 | 2010-07-01 | アルカームズ,インコーポレイテッド | Coacervation process |
RU2440097C2 (en) | 2007-04-23 | 2012-01-20 | Интарсия Терапьютикс, Инк. | Method of treating insulin-independent diabetes and obesity, osmotic delivery system and method for making it |
WO2008157540A1 (en) * | 2007-06-20 | 2008-12-24 | Alkermes, Inc. | Quench liquids and washing systems for production of microparticles |
ES2718612T3 (en) | 2007-12-20 | 2019-07-03 | Evonik Corp | Procedure for preparing microparticles that have a low volume of residual solvent |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
US20110263496A1 (en) | 2008-05-21 | 2011-10-27 | Amylin Pharmaceuticals, Inc. | Exendins to lower cholesterol and triglycerides |
GB0810990D0 (en) * | 2008-06-16 | 2008-07-23 | Q Chip Ltd | Device and method of making solid beads |
CN102083419A (en) * | 2008-07-01 | 2011-06-01 | 日东电工株式会社 | Pharmaceutical composition containing surface-coated microparticles |
KR101760953B1 (en) | 2008-09-04 | 2017-07-24 | 아밀린 파마슈티칼스, 엘엘씨. | Sustained release formulations using non-aqueous carriers |
US20100189800A1 (en) * | 2009-01-23 | 2010-07-29 | Peter Markland | Continous double emulsion process for making microparticles |
EP3323423B1 (en) | 2009-09-28 | 2020-06-17 | Intarcia Therapeutics, Inc | Rapid establishment and/or termination of substantial steady-state drug delivery |
WO2011063414A1 (en) | 2009-11-23 | 2011-05-26 | Amylin Pharmaceuticals, Inc. | Polypeptide conjugate |
UA111162C2 (en) | 2010-08-04 | 2016-04-11 | Флекшен Терап'Ютікс, Інк. | INJECTION COMPOSITION OF TRIAMCINOLONE ACETONIDE FOR TREATMENT OF PAIN |
CA2813301A1 (en) * | 2010-09-30 | 2012-04-05 | Evonik Corporation | Method for removing residual organic solvent from microparticles |
US20120082731A1 (en) * | 2010-09-30 | 2012-04-05 | Adrian Raiche | Method For Removing Residual Organic Solvent From Microparticles |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
WO2013019280A1 (en) * | 2011-08-04 | 2013-02-07 | Flexion Therapeutics | Corticosteroids for the treatment of joint pain |
US20160039877A1 (en) | 2013-03-15 | 2016-02-11 | Shenzhen Hightide Biopharmaceutical, Ltd. | Compositions and methods of using islet neogenesis peptides and analogs thereof |
WO2015082562A1 (en) * | 2013-12-05 | 2015-06-11 | Alrise Biosystems Gmbh | Process for the production of drug formulations for oral administration |
KR101738127B1 (en) * | 2014-08-08 | 2017-05-22 | (주)비씨월드제약 | A method for producing drug-containing sustained release micro particle |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
HUE055728T2 (en) | 2015-05-22 | 2021-12-28 | Univ Leland Stanford Junior | Treatment of post-bariatric hypoglycemia with exendin(9-39) |
EP3302354B1 (en) | 2015-06-03 | 2023-10-04 | i2o Therapeutics, Inc. | Implant placement systems |
EP3307245A1 (en) | 2015-06-11 | 2018-04-18 | Alrise Biosystems GmbH | Process for the preparation of drug loaded microparticles |
US10653753B2 (en) | 2016-03-04 | 2020-05-19 | Eiger Biopharmaceuticals, Inc. | Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives |
WO2017200943A1 (en) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
WO2018057977A1 (en) | 2016-09-23 | 2018-03-29 | Delpor, Inc. | Stable compositions for incretin mimetic compounds |
JP2019535734A (en) | 2016-11-21 | 2019-12-12 | アイガー・バイオファーマシューティカルズ・インコーポレイテッドEiger Biopharmaceuticals, Inc. | Buffered formulation of exendin (9-39) |
KR20190104039A (en) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Methods Including Continuous Administration of GLP-1 Receptor Agonists and Co-administration of Drugs |
US10772929B2 (en) | 2017-05-11 | 2020-09-15 | Shenzhen Hightide Biopharmaceutical, Ltd. | Use of peptide compounds in treating acute pancreatitis |
CN109718212A (en) * | 2017-10-30 | 2019-05-07 | 浙江圣兆药物科技股份有限公司 | A method of reducing low solvent flashing benzyl alcohol in Risperidone microballoon |
CN109718209B (en) * | 2017-10-30 | 2021-03-05 | 浙江圣兆药物科技股份有限公司 | Freeze-drying method of risperidone microspheres with low ethanol residues |
EP4125823A1 (en) | 2020-03-30 | 2023-02-08 | Biological E Limited | Risperidone microspheres, process for their prepartion and uses thereof |
CN112755245B (en) * | 2020-11-26 | 2022-12-02 | 北京尚盛楚逸医药科技有限公司 | Polylactic acid filling agent for injection and preparation method thereof |
KR20230132666A (en) * | 2022-03-08 | 2023-09-18 | 동국제약 주식회사 | Preparing method of microspheres improved suspension performance using coacervation method |
Family Cites Families (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE634668A (en) * | 1962-07-11 | |||
BE744162A (en) * | 1969-01-16 | 1970-06-15 | Fuji Photo Film Co Ltd | ENCAPSULATION PROCESS |
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
DE2010115A1 (en) * | 1970-03-04 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Process for the production of micro-granules |
US3773910A (en) * | 1971-11-02 | 1973-11-20 | Wilson & Chandler | Preparation of solid composition of matter containing large percentages of sulfuric acid |
JPS523342B2 (en) * | 1972-01-26 | 1977-01-27 | ||
GB1413186A (en) * | 1973-06-27 | 1975-11-12 | Toyo Jozo Kk | Process for encapsulation of medicaments |
JPS523653A (en) * | 1975-06-27 | 1977-01-12 | Fuji Photo Film Co Ltd | Process for producing fine polymer particles |
CH649217A5 (en) * | 1977-08-25 | 1985-05-15 | Sandoz Ag | BROMOCRIPTIN CONTAINING MICROCAPSULES. |
US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
PH19942A (en) | 1980-11-18 | 1986-08-14 | Sintex Inc | Microencapsulation of water soluble polypeptides |
JPS57119318A (en) * | 1981-01-16 | 1982-07-24 | Minolta Camera Co Ltd | Filter having special effect |
US4530840A (en) * | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
US5385738A (en) * | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
US5639639A (en) | 1983-11-02 | 1997-06-17 | Genzyme Corporation | Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof |
US4840896A (en) | 1983-11-02 | 1989-06-20 | Integrated Genetics, Inc. | Heteropolymeric protein |
US4923805A (en) | 1983-11-02 | 1990-05-08 | Integrated Genetics, Inc. | Fsh |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4804663A (en) | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
IE59361B1 (en) * | 1986-01-24 | 1994-02-09 | Akzo Nv | Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension |
US4737437A (en) * | 1986-03-27 | 1988-04-12 | East Shore Chemical Co. | Light sensitive diazo compound, composition and method of making the composition |
US5000886A (en) * | 1987-05-26 | 1991-03-19 | American Cyanamid Company | Silicone-hardened pharmaceutical microcapsules and process of making the same |
US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
GB8723846D0 (en) | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
WO1989003678A1 (en) | 1987-10-30 | 1989-05-05 | Stolle Research & Development Corporation | Low residual solvent microspheres and microencapsulation process |
US5271945A (en) | 1988-07-05 | 1993-12-21 | Takeda Chemical Industries, Ltd. | Sustained release microcapsule for water soluble drug |
US5158952A (en) | 1988-11-07 | 1992-10-27 | Janssen Pharmaceutica N.V. | 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use |
IL92344A0 (en) * | 1989-01-04 | 1990-07-26 | Gist Brocades Nv | Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules |
US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
ATE99546T1 (en) | 1989-05-01 | 1994-01-15 | Alkermes Inc | PROCESS FOR PRODUCTION OF SMALL PARTICLES OF BIOLOGICALLY ACTIVE MOLECULES. |
DE69024953T3 (en) * | 1989-05-04 | 2005-01-27 | Southern Research Institute, Birmingham | encapsulation |
HU221294B1 (en) * | 1989-07-07 | 2002-09-28 | Novartis Ag | Process for producing retarde compositions containing the active ingredient in a polymeric carrier |
US5225205A (en) | 1989-07-28 | 1993-07-06 | Debiopharm S.A. | Pharmaceutical composition in the form of microparticles |
KR920702383A (en) | 1989-08-28 | 1992-09-03 | 원본미기재 | Biocorrosive polymers useful for controlling the release of therapeutic agents |
US5707644A (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
ES2084712T3 (en) * | 1989-11-06 | 1996-05-16 | Alkermes Inc | METHOD FOR PRODUCING PROTEIN MICROSPHERES. |
US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
US5126147A (en) | 1990-02-08 | 1992-06-30 | Biosearch, Inc. | Sustained release dosage form |
US5478564A (en) * | 1990-02-22 | 1995-12-26 | Teva Pharmaceutical Industries, Ltd. | Preparation of microparticles for controlled release of water-soluble substances |
IT1243390B (en) | 1990-11-22 | 1994-06-10 | Vectorpharma Int | PHARMACEUTICAL COMPOSITIONS IN THE FORM OF PARTICLES SUITABLE FOR THE CONTROLLED RELEASE OF PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PROCEDURE FOR THEIR PREPARATION. |
CA2102507A1 (en) | 1991-05-07 | 1992-11-08 | Judith P. Kitchell | A controlled, sustained release delivery system for smoking cessation |
HU222501B1 (en) * | 1991-06-28 | 2003-07-28 | Endorecherche Inc. | Controlled release pharmaceutical composition containing mpa or mga and process for its preparation |
US5658593A (en) * | 1992-01-16 | 1997-08-19 | Coletica | Injectable compositions containing collagen microcapsules |
DK0632820T3 (en) * | 1992-02-28 | 2000-10-02 | Collagen Corp | Highly concentrated, homogenized collagen compositions |
US5656297A (en) * | 1992-03-12 | 1997-08-12 | Alkermes Controlled Therapeutics, Incorporated | Modulated release from biocompatible polymers |
US5912015A (en) | 1992-03-12 | 1999-06-15 | Alkermes Controlled Therapeutics, Inc. | Modulated release from biocompatible polymers |
US6514533B1 (en) | 1992-06-11 | 2003-02-04 | Alkermas Controlled Therapeutics, Inc. | Device for the sustained release of aggregation-stabilized, biologically active agent |
US5716644A (en) * | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
US5288337A (en) * | 1992-06-25 | 1994-02-22 | Siemens Solar Industries, L.P. | Photovoltaic module with specular reflector |
WO1994010982A1 (en) | 1992-11-17 | 1994-05-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Sustained-release microsphere containing antipsychotic and process for producing the same |
EP0674506B1 (en) * | 1992-12-02 | 2000-08-23 | Alkermes Controlled Therapeutics, Inc. | Controlled release growth hormone containing microspheres |
PT686045E (en) | 1993-02-23 | 2001-04-30 | Genentech Inc | STABILIZATION BY EXPIPIENTS OF POLYPEPTIDES TREATED WITH ORGANIC SOLVENTS |
US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
TW404844B (en) | 1993-04-08 | 2000-09-11 | Oxford Biosciences Ltd | Needleless syringe |
US5424286A (en) | 1993-05-24 | 1995-06-13 | Eng; John | Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same |
US5650173A (en) * | 1993-11-19 | 1997-07-22 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of biodegradable microparticles containing a biologically active agent |
EP2283821A1 (en) * | 1993-11-19 | 2011-02-16 | Alkermes, Inc. | Preparation of biodegradable microparticles containing a biologically active agent |
NZ276088A (en) * | 1993-11-19 | 1999-07-29 | Janssen Pharmaceutica Nv | [(1,2-benzisoxazol-3-yl)-1-piperidinyl-alkyl-6,7,8,9-tetrahydro-4h- pyrido[1,2-a]-pyrimidin-4-one derivatives (ie risperidone) |
US5922253A (en) | 1995-05-18 | 1999-07-13 | Alkermes Controlled Therapeutics, Inc. | Production scale method of forming microparticles |
US6369116B1 (en) | 1995-06-02 | 2002-04-09 | Oculex Pharmaceuticals, Inc. | Composition and method for treating glaucoma |
US5747058A (en) * | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
US5904935A (en) | 1995-06-07 | 1999-05-18 | Alza Corporation | Peptide/protein suspending formulations |
US5942253A (en) * | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF |
SE505146C2 (en) | 1995-10-19 | 1997-06-30 | Biogram Ab | Particles for delayed release |
AU2043297A (en) | 1996-03-28 | 1997-10-17 | Takeda Chemical Industries Ltd. | Sustained-release preparation and its production |
US5792477A (en) * | 1996-05-07 | 1998-08-11 | Alkermes Controlled Therapeutics, Inc. Ii | Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent |
US5945126A (en) * | 1997-02-13 | 1999-08-31 | Oakwood Laboratories L.L.C. | Continuous microsphere process |
TW577759B (en) | 1997-04-18 | 2004-03-01 | Ipsen Pharma Biotech | Sustained release compositions in the form of microcapsules or implants and the process for their preparation |
US6113947A (en) | 1997-06-13 | 2000-09-05 | Genentech, Inc. | Controlled release microencapsulated NGF formulation |
GB9718986D0 (en) | 1997-09-09 | 1997-11-12 | Danbiosyst Uk | Controlled release microsphere delivery system |
US5989463A (en) * | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
GB9805417D0 (en) * | 1998-03-14 | 1998-05-06 | Core Technologies Limited | Production of microparticles |
CA2335460A1 (en) | 1998-06-18 | 1999-12-23 | Johns Hopkins University School Of Medicine | Polymers for delivery of nucleic acids |
US6194006B1 (en) | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
US20030087820A1 (en) | 1999-01-14 | 2003-05-08 | Young Andrew A. | Novel exendin agonist formulations and methods of administration thereof |
US6268630B1 (en) * | 1999-03-16 | 2001-07-31 | Sandia Corporation | Silicon-on-insulator field effect transistor with improved body ties for rad-hard applications |
WO2000059476A1 (en) | 1999-04-05 | 2000-10-12 | Pharmaceutical Discovery Corporation | Methods for fine powder formation |
US6291013B1 (en) | 1999-05-03 | 2001-09-18 | Southern Biosystems, Inc. | Emulsion-based processes for making microparticles |
SE9903236D0 (en) | 1999-09-10 | 1999-09-10 | Astra Ab | Method of obtaining microparticles |
US6284283B1 (en) | 1999-10-21 | 2001-09-04 | Alkermes Controlled Therapeutics, Inc. | Method of producing sub-micron particles of biologically active agents and uses thereof |
US6465425B1 (en) | 2000-02-10 | 2002-10-15 | Alkermes Controlled Therapeutics, Inc. | Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins |
US6495164B1 (en) | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
AUPQ930900A0 (en) | 2000-08-10 | 2000-08-31 | Wright, James Grant | Dispensing device |
US6824822B2 (en) * | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
US6558702B2 (en) | 2001-04-13 | 2003-05-06 | Alkermes Controlled Therapeutics, Inc. | Method of modifying the release profile of sustained release compositions |
US20030003074A1 (en) | 2001-06-14 | 2003-01-02 | Macromed, Inc. | Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders |
AUPR956801A0 (en) * | 2001-12-17 | 2002-01-24 | Kirk, Wayne Anthony | Solar energy conversion system |
US7953820B2 (en) * | 2002-09-11 | 2011-05-31 | Hughes Network Systems, Llc | Method and system for providing enhanced performance of web browsing |
AU2003277446A1 (en) * | 2002-10-17 | 2004-05-04 | Alkermes Controlled Therapeutics, Inc. Ii | Microencapsulation and sustained release of biologically active polypeptides |
AU2003284028B2 (en) | 2002-10-17 | 2007-05-10 | Alkermes, Inc. | Sustained release profile modification |
US6887613B2 (en) | 2002-12-04 | 2005-05-03 | General Motors Corporation | Corrosion resistant PEM fuel cell |
US6968927B2 (en) | 2003-10-10 | 2005-11-29 | Brian Scura | Bicycle force balancing mechanism with a brake arm actuation assembly and a pivot member for dual main brake cable segments |
US7456254B2 (en) * | 2004-04-15 | 2008-11-25 | Alkermes, Inc. | Polymer-based sustained release device |
US20060110423A1 (en) * | 2004-04-15 | 2006-05-25 | Wright Steven G | Polymer-based sustained release device |
JP5892782B2 (en) * | 2011-12-21 | 2016-03-23 | 大和ハウス工業株式会社 | Curtain wall type outer wall structure |
-
2001
- 2001-08-31 US US09/942,631 patent/US6824822B2/en not_active Expired - Lifetime
-
2002
- 2002-08-26 MX MXPA04001765A patent/MXPA04001765A/en active IP Right Grant
- 2002-08-26 ES ES02759445T patent/ES2362865T3/en not_active Expired - Lifetime
- 2002-08-26 EP EP02759445A patent/EP1420762B1/en not_active Expired - Lifetime
- 2002-08-26 PT PT02759445T patent/PT1420762E/en unknown
- 2002-08-26 IL IL16037802A patent/IL160378A0/en unknown
- 2002-08-26 JP JP2003524554A patent/JP2005502674A/en active Pending
- 2002-08-26 DE DE60239469T patent/DE60239469D1/en not_active Expired - Lifetime
- 2002-08-26 NZ NZ531165A patent/NZ531165A/en not_active IP Right Cessation
- 2002-08-26 AT AT02759445T patent/ATE501711T1/en active
- 2002-08-26 DK DK02759445.6T patent/DK1420762T3/en active
- 2002-08-26 CA CA002454027A patent/CA2454027C/en not_active Expired - Lifetime
- 2002-08-26 WO PCT/US2002/026953 patent/WO2003020245A1/en active IP Right Grant
- 2002-08-26 EP EP10175736A patent/EP2283820A1/en not_active Withdrawn
-
2004
- 2004-02-12 IL IL160378A patent/IL160378A/en unknown
- 2004-10-04 US US10/956,092 patent/US20050079224A1/en not_active Abandoned
- 2004-11-25 HK HK04109322.6A patent/HK1066465A1/en not_active IP Right Cessation
-
2005
- 2005-12-21 US US11/312,371 patent/US7223440B2/en not_active Expired - Lifetime
-
2007
- 2007-04-19 US US11/785,638 patent/US7524530B2/en not_active Expired - Lifetime
- 2007-07-13 US US11/826,383 patent/US20080050447A1/en not_active Abandoned
- 2007-07-13 US US11/826,382 patent/US20080051561A1/en not_active Abandoned
-
2009
- 2009-03-20 US US12/382,637 patent/US7875310B2/en not_active Expired - Fee Related
-
2010
- 2010-10-12 JP JP2010229366A patent/JP2011037882A/en active Pending
- 2010-12-14 US US12/967,757 patent/US8187672B2/en not_active Expired - Lifetime
-
2011
- 2011-05-25 CY CY20111100509T patent/CY1112348T1/en unknown
-
2013
- 2013-06-20 JP JP2013129973A patent/JP5841565B2/en not_active Expired - Lifetime
-
2015
- 2015-09-10 JP JP2015178419A patent/JP2015227383A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2454027A1 (en) | Residual solvent extraction method and microparticles produced thereby | |
EP1209563A3 (en) | Method and system for allowing code to be securely initialized in a computer | |
WO2003056473A3 (en) | System, method, and article of manufacture for profiling an application targeted for reconfigurable logic using calls to profiling functions | |
WO2005008478A3 (en) | Method and apparatus for performing native binding | |
DE69940561D1 (en) | RESIN COMPOSITION, POLYMER AND METHOD FOR THE PRODUCTION THEREOF | |
AU2003277881A1 (en) | Middleware application message/event model | |
DE502004004043D1 (en) | DEVICE AND METHOD FOR PROCESSING AT LEAST TWO INPUT VALUES | |
WO1998046195A3 (en) | Tooth surface treatment composition and methods | |
DE59704783D1 (en) | BEARING SHELL WITH HOLDING CAMS AND METHOD FOR THE PRODUCTION THEREOF | |
WO2002004110A3 (en) | Method for preparing an acid catalyst based on mass sulphated zirconium, catalyst obtainable by said method and uses thereof | |
DE60039191D1 (en) | METHOD, DEVICE AND SYSTEM FOR A VIDEO PROGRAM PLAY FUNCTIONALITY IN A MOBILE PHONE | |
WO2002073355A3 (en) | System for configuration programming | |
CA2375136A1 (en) | Method of reclaiming crosslinked rubber and molding of reclaimed rubber | |
GB2364317B (en) | Organic anti-reflective coating polymer,anti-reflective coating composition comprising the same and method of preparation thereof | |
DE69907375D1 (en) | Tire containing an electric generator for feeding devices built into the tire, and method of manufacturing the same. | |
WO2002053598A3 (en) | Manufacturing process for porous material | |
ZA200306548B (en) | Method for preventing polymerization in an acrylic acid manufacturing process. | |
WO2002040480A3 (en) | Crf receptor antagonists and methods relating thereto | |
SG106646A1 (en) | Organic anti-reflective coating polymers, anti-reflective coating composition comprising the same and preparation methods thereof | |
WO2004091789A8 (en) | Method for treating hydroprocessing catalysts with an orthophthalate and sulphuration method using the same | |
GB0115816D0 (en) | Organic anti-reflective coating polymer,anti-reflective coating composition comprising the same and method of preparation thereof | |
SG95682A1 (en) | Additive for resin, additive-containing resin, and method for producing the same | |
WO2005019421A3 (en) | Crosslinking within coordination complexes | |
ZA200110172B (en) | Method of producing novolak resin. | |
WO2004102556A3 (en) | Disc drive apparatus, and method for timing recalibration in a disc drive apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20220826 |